Picture a three-hospital system with one shared materials team. On a Monday in March, a distributor emails that a single-source product line is on allocation: forty percent of normal volume for at least ten weeks, no firm end date. Nobody in the building has bought from anyone else in six years. The contract was renegotiated twice, the preference cards were rewritten around one vendor’s packaging, and the sales rep is a friend of half the surgeons. That’s what a single-source relationship looks like from the inside, comfortable right up to the day it isn’t.
This is a composite, not a single customer story, but the sequence is familiar to anyone who has run supply chain through a shortage. What follows is how that Monday plays out, what the scramble reveals about the real price of having only one vendor, and how to decide whether a second one is worth carrying before the next allocation notice arrives.
Week one: finding out what you actually depend on
The first thing the materials director does is try to answer a question that should take ten minutes and takes four days: which SKUs from this vendor are in use, at what volume, in which rooms? The ERP shows purchase history, but not substitution tolerance. A purchasing record can’t tell you whether a line item is interchangeable with three competitors’ versions or whether two surgeons will refuse anything else.
So the team builds a quick triage sheet. Every affected item gets one of three labels: clinically flexible (staff will accept a comparable alternative), flexible with a trial (needs a short evaluation and some in-service time), and locked (surgeon-specific, tied to a validated workflow). In the scenario, the split is roughly sixty, thirty, ten. The sixty percent can move within days if someone has a price and a lead time. The ten percent is where the real exposure sits, and it’s usually a smaller list than the loudest voices suggest.
Notice what this exercise really is: an inventory of switching cost. If you’d built it a year earlier, you’d have walked into week one with answers. Even if you never add a second vendor, that sheet is worth maintaining on its own.
Week two: the emergency qualification bill
With allocation confirmed, the team starts buying from a second supplier on the spot market and through a regional distributor. Here the cost nobody budgeted for shows up. A vendor you’ve never used has to clear a stack of internal steps before a single box reaches a sterile processing department:
- Credentialing and vendor-access registration
- Contract language, including return terms, recall notification, and indemnification
- Value analysis review, even a shortened one
- Item master setup, pricing loads, and unit-of-measure mapping
- Reprocessing instructions reviewed against what SPD can actually run
- In-service sessions across shifts
In a calm quarter, that list takes six to twelve weeks. Under pressure, the team compresses it to eleven days, which means skipped steps and one avoidable error: a unit-of-measure mismatch that sends cases of items to the wrong par locations and leaves a room short on the morning it matters. Expedited freight adds another layer. Premium shipping, a rush fee from the distributor, and a price roughly eighteen percent above what the contract would have been if negotiated in advance.
Add it up and the emergency qualification costs more than the administrative overhead of simply keeping a second vendor warm for two years. That’s the arithmetic most single-source defenders skip. They compare the ongoing cost of two relationships against the cost of one, rather than against the cost of building the second one in a panic.
Week four: what a “warm” second vendor would have looked like
Suppose the same system had qualified a second supplier eighteen months earlier and bought a small, steady slice from them. Call it ten to fifteen percent of volume in the flexible category. The administrative load is real but modest: one more contract to track, one more vendor in the access system, one more set of rebate tiers to manage, and a quarterly check that the item master stays current.
The benefits stack up differently than the sales pitch suggests. Yes, there’s supply continuity. But there’s also price discipline. A primary vendor who knows you have a live alternative negotiates differently at renewal than one who knows you’d need a quarter to switch. I’d go further: in most contract cycles, the leverage gained pays for a large share of the added administration even if no disruption ever happens. That’s an opinion, not a guarantee, and it depends heavily on how much of your spend sits in categories where alternatives truly exist.
The warm vendor also keeps your own staff in practice. Someone in SPD has handled their packaging, someone in the OR has opened their product, someone in accounts payable has processed their invoices. When the allocation notice arrives, you’re scaling a relationship, not starting one.
Where dual-sourcing doesn’t pay
It would be dishonest to present this as universally right. Three situations argue against it.
Low-volume, high-customization items. If an item is used in forty cases a year by two surgeons, the administrative cost of a second source can exceed the entire annual spend. Carry extra safety stock instead.
Tightly bundled contracts. Some agreements tie tier pricing or rebates to share-of-spend thresholds. Moving ten percent of volume away from the primary can trigger a price increase on the other ninety, wiping out the benefit. Read the tier language before you split anything.
Categories with a single credible manufacturer. Some product families simply don’t have a second source that meets spec. Pretending otherwise creates an expensive paper relationship that fails the moment you rely on it. The FDA’s public device shortage list is a reasonable sanity check on which categories have a history of constrained supply and whether alternatives have actually existed during past events.
A fair rule of thumb: dual-source where the item is high volume, clinically interchangeable at the triage level, and sourced from a manufacturer or distributor with a concentrated supply chain. Leave the rest alone and manage it with buffer inventory.
Running the numbers before the next notice
The decision comes down to a simple comparison, and it’s worth doing on paper for your top twenty categories by spend. For each one, estimate three figures: the annual administrative cost of carrying a second vendor (contracting, access, item master maintenance, staff time), the probable cost of an emergency switch (rush freight, price premium, error cost, staff overtime), and the likelihood of a disruption over a three-year window. Multiply the second by the third, then compare to the first.
Be honest about probability. After a few years of calm, people underweight it. After a shortage, they overweight it. A reasonable approach is to use your own history: how many allocation notices, backorders over thirty days, or recall-driven stock-outs have you had from this vendor family in five years? That number is better than any industry estimate.
When you go shopping for the second source, evaluate the catalog depth first. A secondary supplier that covers only a fraction of what you buy forces you back to the primary for everything else, so look for breadth in the categories you’ve flagged as flexible. Suppliers of minimally invasive surgical instruments vary widely in how much of the standard hand-instrument range they cover under one agreement, and that breadth determines whether a second relationship is a real hedge or a token one.
Making the second vendor stick
The common failure after a shortage is that the temporary vendor gets dropped the moment the primary recovers. Volume drifts back to ninety-nine percent, the relationship withers, and eighteen months later you’re back in the same position with a lapsed credential and a stale price file. If you want the hedge, fund it deliberately.
Set a floor share, even five or ten percent, in categories where the alternative is genuinely interchangeable, and write it into your internal purchasing policy so it survives staff turnover. Put the second vendor’s contract renewal on the same calendar as the primary’s. Run one joint review a year where value analysis checks that item master data, pricing, and reprocessing instructions are still current for both. Tie the arrangement to a named owner, because relationships without owners decay.
For standard reusable and single-use laparoscopic surgical instruments, where interchangeability is highest and clinical sign-off is quickest, a ten percent floor tends to be enough to keep a second source credentialed and responsive without meaningfully diluting the primary contract’s leverage. High-customization categories deserve a different treatment: documented substitution plans, extra safety stock, and an annual conversation with the surgeons about what they’d actually accept in a pinch.
In the scenario above, the system rides out the ten weeks, absorbs the premium, and by summer decides to qualify a second vendor properly. The cost of that project is roughly a quarter of what the emergency scramble cost. Whether your numbers look the same depends on your categories, your contracts, and your history. But run them before the next notice, not after.
